Ceramide in pseudomonas aeruginosa infections and cystic fibrosis

Cellular Physiology and Biochemistry

Volumn 26, Issue 1, 2010, Pages 57-66

  Becker, Katrin Anne ^a   Grassmé, Heike ^a   Zhang, Yang ^a   Gulbins, Erich ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Ceramide; Cystic fibrosis; P. aeruginosa; Sphingomyelinase

Indexed keywords

AMITRIPTYLINE; CERAMIDE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 8; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

BRONCHUS MUCOSA; CHRONIC INFLAMMATION; CYSTIC FIBROSIS; CYTOKINE RELEASE; FORCED EXPIRATORY VOLUME; HUMAN; INFECTION SENSITIVITY; INTERNALIZATION; LIPID RAFT; MUCOCILIARY CLEARANCE; NEISSERIA GONORRHOEAE; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; REVIEW;

BACTERIA (MICROORGANISMS); MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

EID: 77952925551     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315106     Document Type: Review

References (88)

1. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080. (Pubitemid 19231815)
2. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui LC, Collins FS: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-1065. (Pubitemid 19231813)
3. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073 (Pubitemid 19231814)
4. CF foundation, patient registry annual reports, Bethesda, Maryland, USA, 2009.
5. Matsui H, Verghese MW, Kesimer M, Schwab UE, Randell SH, Sheehan JK, Grubb BR, Boucher RC: Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces. J Immunol 2005;175:1090-1099.
6. Boucher RC: Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 2007;58:157-170.
7. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM: Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;88:553-560.
8. Smith JJ, Travis SM, Greenberg EP, Welsh MJ: Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996;85:229-236.
9. Pier GB, Grout M, Zaidi TS, Olsen JC, Johnson LG, Yankaskas JR, Goldberg JB: Role of mutant CFTR in hypersusce-ptibility of cystic fibrosis patients to lung infections. Science 1996;271:64-67.
10. Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, Huang P, Tong J, Naren AP, Bindokas V, Palfrey HC, Nelson DJ: CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 2006;8:933-944.
11. Teichgräber V, Ulrich M, Endlich N, Riethmuller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kürthy G, Schmid KW, Weller M, Tümmler B, Lang F, Grassme H, Döring G, Gulbins E: Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008;14:382-391.
12. Singer SJ, Nicolson GL: The fluid mosaic model of the structure of cell membranes. Science 1972;175:720-731.
13. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997;387:569-572.
14. Brown DA, London E: Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998;14:111-136.
15. Kolesnick RN, Goni FM, Alonso A: Compartmentalization of ceramide signaling: physical foundations and biological effects. J Cell Physiol 2000;184:285-300.
16. Xu X, Bittman R, Duportail G, Heissler D, Vilcheze C, London E: Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebro-sides, and ceramide. J Biol Chem 2001;276:33540-33546.
17. Megha, London E: Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J Biol Chem 279;2004:9997-10004.
18. Eggeling C, Ringemann C, Medda R, Schwarzmann G, Sandhoff K, Polyakova S, Belov VN, Hein B, von Middendorff C, Schönle A, Hell SW: Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature 2009;457:1159-1162.
19. Hakomori S: Chemistry of Glycosphin-golipids. In: Kanfer JN, Hakomori S, editors. Sphingolipid Biochemistry. New York and London: Plenum Press 1983, pp 1-165.
20. Quintern LE, Schuchman EH, Levran O, Suchi M, Ferlinz K, Reinke H, Sandhoff K, Desnick RJ: Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. Embo J 1989;8:2469-2473.
21. Kitatani K, Idkowiak-Baldys J, Hannun YA: The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 2007;20:1010-1018.
22. Gulbins E, Kolesnick R: Raft ceramide in molecular medicine. Oncogene 2003;22:7070-7077.
23. Hannun YA, Obeid LM: Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008;9:139-150.
24. Okino N, He X, Gatt S, Sandhoff K, Ito M, Schuchman EH: The reverse activity of human acid ceramidase. J Biol Chem 2003;278:29948-29953.
25. Ishibashi Y, Nakasone T, Kiyohara M, Horibata Y, Sakaguchi K, Hijikata A, Ichinose S, Omori A, Yasui Y, Imamura A, Ishida H, Kiso M, Okino N, Ito M: A novel endoglycoceramidase hydrolyzes oligogalactosylceramides to produce galactooligo-saccharides and ceramides. J Biol Chem 2007;282:11386-11396.
26. Mitra P, Maceyka M, Payne SG, Lamour N, Milstien S, Chalfant CE, Spiegel S: Ceramide kinase regulates growth and survival of A549 human lung adeno-carcinoma cells. FEBS Lett 2007;581:735-740.
27. Hanada K, Kumagai K, Tomishige N, Kawano M: CERT and intracellular trafficking of ceramide. Biochim Biophys Acta 2007;1771:644-653.
28. Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I: The cellular trafficking and zinc dependence of secretory and lysosomal sphingomye-linase, two products of the acid sphingomyelinase gene. J Biol Chem 1998;273:18250- 18259.
29. 2+ - stimulated sphingomye-linase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem. 1996;271:18431-18436.
30. Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, Gulbins E: CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 2001;276:20589-20596.
31. Bao JX, Jin S, Zhang F, Wang ZC, Li NJ, Li PL: Activation of membrane NADPH Oxidase associated with lysosome-targeted acid sphingomyelinase in coronary endothelial cells. Antioxid Redox Signal. 2010;12:703-712.
32. Herz J, Pardo J, Kashkar H, Schramm M, Kuzmenkina E, Bos E, Wiegmann K, Wallich R, Peters PJ, Herzig S, Schmelzer E, Krönke M, Simon MM, Utermöhlen O: Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes. Nat Immunol 2009;10:761-768.
33. Cremesti A, Paris F, Grassme H, Holler N, Tschopp J, Fuks Z, Gulbins E, Kolesnick R: Ceramide enables fas to cap and kill. J Biol Chem 2001;276:23954-23961. (Pubitemid 37410795)
34. Dumitru CA, Gulbins E: TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene 2006;25:5612-5625.
35. Grassmé H, Jendrossek V, Bock J, Riehle A, Gulbins E: Ceramide-rich membrane rafts mediate CD40 clustering. J Immunol 2002;168:298-307.
36. Goggel R, Winoto-Morbach S, Vielhaber G, Imai Y, Lindner K, Brade L, Brade H, Ehlers S, Slutsky AS, Schutze S, Gulbins E, Uhlig S: PAF-mediated pulmonary edema: a new role for acid sphingomye-linase and ceramide. Nat Med 2004;10:155-160.
37. Grassmé H, Jendrossek V, Riehle A, von Kurthy G, Berger J, Schwarz H, Weller M, Kolesnick R, Gulbins E: Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 2003;9:322-330.
38. Grassme H, Gulbins E, Brenner B, Ferlinz K, Sandhoff K, Harzer K, Lang F, Meyer TF: Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphago-cytic cells. Cell 1997;91:605-615.
39. Grassmé H, Riehle A, Wilker B, Gulbins E. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem 2005;280:26256-26262.
40. Gassert E, Avota E, Harms H, Krohne G, Gulbins E, Schneider-Schaulies S: Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression. PLoS Pathog 2009;5:e1000623.
41. Rotolo JA, Zhang J, Donepudi M, Lee H, Fuks Z, Kolesnick R: Caspase-dependent and-independent activation of acid sphingomyelinase signaling. J Biol Chem 2005;280:26425-26434.
42. Nurminen TA, Holopainen JM, Zhao H, Kinnunen PK: Observation of topical catalysis by sphingomyelinase coupled to microspheres. J Am Chem Soc 2002;124:12129-12134.
43. Zhang AY, Yi F, Jin S, Xia M, Chen QZ, Gulbins E, Li PL: Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal 2007;9:817-828.
44. Heinrich M, Wickel M, Schneider-Brachert W, Sandberg C, Gahr J, Schwandner R, Weber T, Saftig P, Peters C, Brunner J, Kronke M, Schutze S: Cathepsin D targeted by acid sphingo-myelinase-derived ceramide. Embo J 1999;18:5252-5263.
45. Huwiler A, Johansen B, Skarstad A, Pfeilschifter J: Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. Faseb J 2001;15:7-9.
46. Zhang Y, Yao B, Delikat S, Bayoumy S, Lin XH, Basu S, McGinley M, Chan-Hui PY, Lichenstein H, Kolesnick R: Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997; 89: 63-72.
47. Dobrowsky RT, Hannun YA: Ceramide-activated protein phosphatase: partial purification and relationship to protein phosphatase 2A. Adv Lipid Res 1993;25:91-104.
48. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K: PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. Embo J 1995;14:1961-1969.
49. Huwiler A, Fabbro D, Pfeilschifter J: Selective ceramide binding to protein kinase C-alpha and delta isoenzymes in renal mesangial cells. Biochemistry 13;37:14556-14562.
50. + channel in T lymphocytes upon Fas stimulation. J Biol Chem 1996;271:20465-20469.
51. Gulbins E, Szabo I, Baltzer K, Lang F: Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc Natl Acad Sci USA 1997;94:7661-7666.
52. Lepple-Wienhues A, Belka C, Laun T, Jekle A, Walter B, Wieland U, Welz M, Heil L, Kun J, Busch G, Weller M, Bamberg M, Gulbins E, Lang F: Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. Proc Natl Acad Sci USA 1999;96:13795-13800.
53. Bock J, Szabo I, Gamper N, Adams C, Gulbins E: Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms. Biochem Biophys Res Commun 2003;305:890-897.
54. Siskind LJ, Colombini M: The lipids C2-and C16-ceramide form large stable channels. Implications for apoptosis. J Biol Chem. 2000;275:38640-38644.
55. Hauck CR, Grassme H, Bock J, Jendrossek V, Ferlinz K, Meyer TF, Gulbins E. Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of Neisseria gonorrhoeae. FEBS Lett 2000;478:260-266.
56. Falcone S, Perrotta C, de Palma C, Pisconti A, Sciorati C, Capobianco A, Rovere-Querini P, Manfredi AA, Clementi M: Activation of acid sphingomyelinase and its inhibition by the nitric oxide cyclic guanosine 3',5'-monophosphate pathway: Key events in Escherichia coli-elicited apoptosis of dendritic cells. J Immunol 2004;173:4452-4463.
57. Esen M, Schreiner B, JendrossekV, Lang F, Fassbender K, Grassme H, Gulbins E: Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 2001;6:431-439.
58. Utermöhlen O, Karow U, Löhler J, Krönke M: Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase. J Immunol 2003;170:2621-2628.
59. McCollister BD, Myers JT, Jones-Carson J, Voelker DR, Vazquez-Torres A: Constitutive acid sphingomyelinase enhances early and late macrophage killing of Salmonella enterica serovar typhimurium. Infect Immun 2007;75:5346-5352.
60. Utermöhlen O, Herz J, Schramm M, Krönke M: Fusogenicity of membranes: The impact of acid sphingomyelinase on innate immune responses. Immunobiology 2008;213:307-314.
61. Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C: Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 1996;183:1037-1044.
62. Fischer H, Ellström P, Ekström K, Gustafsson L, Gustafsson M, Svanborg C: Ceramide as a TLR4 agonist: a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell Microbiol 2007;9:1239-1251.
63. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV: Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1006;109:1019-1029.
64. Yu H, Zeidan YH, Wu BX, Jenkins RW, Flotte TR, Hannun YA, Virella-Lowell I: Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Cell Mol Biol 2009;41:367-375.
65. Kowalski MP, Pier GB: Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol 2004;172:418-425.
66. Grassmé H, Kirschnek S, Riethmueller J, Riehle A, von Kurthy G, Lang F, Weller M, Gulbins E: CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science 2000;290:527-530.
67. Kumar V, Becker T, Jansen S, van Barneveld A, Boztug K, Wolfl S, Tümmler B, Stanke F: Expression levels of FAS are regulated through an evolutionary conserved element in intron 2, which modulates cystic fibrosis disease severity. Genes Immun 2008;9:689-696.
68. Pier GB, Grout M, Zaidi TS: Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 1997;94:12088-12093.
69. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, al-Awqati Q: Defective acidification of intracellular organelles in cystic fibrosis. Nature 1991;352:70-73.
70. Haggie PM, Verkman AS: Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages. J Biol Chem 2007;282:31422-31428.
71. Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, Huang P, Tong J, Naren AP, Bindokas V, Palfrey HC, Nelson DJ: CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nature Cell Biol 2006;8:933-944.
72. Zhang Y, Li X, Carpinteiro A, Gulbins E: Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa-induced macrophage apoptosis. J Immunology 2008;181:4247-4254.
73. Becker KA, Riethmüller J, Lüth A, Döring G, Kleuser B, Gulbins E: Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Resp Cell Mol Biol 2009. in press.
74. Guilbault C, De Sanctis JB, Wojewodka G, Saeed Z, Lachance C, Skinner TA, Vilela RM, Kubow S, Lands LC, Hajduch M, Matouk E, Radzioch D: Fenetinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol 2008;38:47-56.
75. Signorelli P, Munoz-Olaya JM, Gagliostro V, Casas J, Ghidoni R, Fabriàs G. Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. Cancer Lett 2009;282:238-243.
76. Hurwitz R, Ferlinz K, Sandhoff K. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol Chem Hoppe Seyler 1994;375:447-450
77. Kornhuber J, Tripal P, Reichel M, Terfloth L, Bleich S, Wiltfang J, Gulbins E: Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. J Med Chem 2008;51:219-237.
78. Verhaeghe C, Delbecque K, de Leval L, Oury C, Bours V: Early inflammation in the airways of a cystic fibrosis foetus. J Cyst Fibros 2007;6:304-308.
79. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW: Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-1082.
80. Oceandy D, McMorran BJ, Smith SN, Schreiber R, Kunzelmann K, Alton EW, Hume DA, Wainwright BJ: Gene complementation of airway epithelium in the cystic fibrosis mouse is necessary and sufficient to correct the pathogen clearance and inflammatory abnormalities. Hum Mol Genet 2002;11:1059-1067.
81. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, Peault B, Puchelle E: Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 2000;23:121-127.
82. Inoue H, Massion PP, Ueki IF, Grattan KM, Hara M, Dohrman AF, Chan B, Lausier JA, Golden JA, Nadel JA: Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils. Am J Respir Cell Mol Biol 1994;11:651-663.
83. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M: Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995;13:257-261.
84. Boland MP, O'Neill LA: Ceramide activates NFkappaB inducing the processing of p105. J Biol Chem 1998;273:15494-15500.
85. Gill JS, Windebank AJ: Ceramide initiates NFkappaB-mediated caspase activation in neuronal apoptosis. Neurobiol Dis 2000;7:448-461.
86. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, Christman JW, Blackwell TS: Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 2000;23:396-403.
87. Tabary O, Escotte S, Couetil JP, Hubert D, Dusser D, Puchelle E, Jacquot J: Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells. Am J Pathol 1999;155:473-481.
88. Riethmüller J, Anthonysamy J, Emilio Serra E, Schwab M, Döring G, Gulbins E: Therapeutic efficacy and safety of amitriptyline in patients with cystic fibrosis. Cell Physiol Biochem 2009;22:405-412.